First-in-class drug approvals
RecordSTO-M2CT8W1DFW-ZP0REVGEVM-VVD25V
China · 2024
First-in-class drug approvals in China were 48 in 2024 (NMPA).
New drug approvals in China: every year, the rank and how it is measured
- Publisher
- NMPA
- Authority tier
- T1 Official
- Retrieved
- 17 Sep 2026
- Status
- Verified
What the source says
China approved 48 first-in-class innovative drugs in 2024, covering nearly 20 therapeutic areas, including oncology, neurological disorders, endocrine diseases and anti-infective medicines, according to a report released by the National Medical Products Administration on Tuesday.
Checked: the figure 48is stated in this passage. If it does not match, the extraction is wrong and we want to know.
Cite this figure
APA
National Medical Products Administration. (2024). China approves 48 innovative drugs in 2024. Retrieved September 17, 2026, from https://english.nmpa.gov.cn/2025-03/19/c_1079532.htm. Via StatOrigin, https://statorigin.org/stat/stat_M2CT8W1DFWZP0REVGEVMVVD25V
Other formats: MLA, Chicago, BibTeX
- MLA
- National Medical Products Administration. "China approves 48 innovative drugs in 2024." 2024, https://english.nmpa.gov.cn/2025-03/19/c_1079532.htm. Accessed 17 Sept. 2026 via StatOrigin, https://statorigin.org/stat/stat_M2CT8W1DFWZP0REVGEVMVVD25V.
- Chicago
- National Medical Products Administration. "China approves 48 innovative drugs in 2024." 2024. https://english.nmpa.gov.cn/2025-03/19/c_1079532.htm. Accessed September 17, 2026. Cited from StatOrigin, https://statorigin.org/stat/stat_M2CT8W1DFWZP0REVGEVMVVD25V.
- BibTeX
- @misc{nmpa2024firstvvd25v, author = {{National Medical Products Administration}}, title = {China approves 48 innovative drugs in 2024}, year = {2024}, howpublished = {StatOrigin, https://statorigin.org}, url = {https://statorigin.org/stat/stat_M2CT8W1DFWZP0REVGEVMVVD25V}, note = {Original source: https://english.nmpa.gov.cn/2025-03/19/c\_1079532.htm. Accessed September 17, 2026.} }
Data published under CC BY 4.0. The citation credits the original publisher and links to this permanent record.
Provenance and verification
Everything needed to check this number yourself, without taking our word for it.
Primary source
- Publisher
- National Medical Products Administration · homepage ↗
- Authority tier
- Tier 1 · Multilateral Official
- Report
- China approves 48 innovative drugs in 2024
- Type
- Press release
- Published
- —
- Locator
- China approves 48 innovative drugs in 2024
- Retrieved
- 17 September 2026
- Link status
- Reachable (HTTP 200)
- Report licence
- See source
Verification
- Status
- Verified
- Review protocol
- Editorial review
- Checked on
- 17 September 2026
- Last revision
- 17 September 2026
- Permanent URL
- /stat/stat_M2CT8W1DFWZP0REVGEVMVVD25V